La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
NUVA Aperçu des actions
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.
| Score flocon de neige | |
|---|---|
| Évaluation | 3/6 |
| Croissance future | 3/6 |
| Performances passées | 1/6 |
| Santé financière | 3/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
NuVasive, Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$39.75 |
| Plus haut sur 52 semaines | US$49.53 |
| Plus bas sur 52 semaines | US$35.17 |
| Bêta | 1.07 |
| 1Variation sur 1 mois | -0.63% |
| Variation sur 3 mois | 0.84% |
| Variation sur 1 an | -8.30% |
| 3Variation sur 3 ans | -22.24% |
| Variation sur 5 ans | -42.71% |
| Évolution depuis l'introduction en bourse | 248.68% |
Nouvelles et mises à jour récentes
Recent updates
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18
What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?
Jan 24NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price
Dec 31Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Dec 05These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Sep 22Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Sep 01NuVasive Likely Undervalued, But It's Hard To Find Catalysts
Aug 17Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M
Aug 03NuVasive: Industry Tailwinds More Than Fairly Priced
Jun 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jun 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
May 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?
Mar 30NuVasive's Turnaround Story Needs A Boost From Better Results
Mar 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
Dec 28Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?
Dec 02NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Oct 21Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital
Sep 29At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
Aug 18NuVasive Still Getting No Love With COVID-19 And Competitive Worries
Aug 12Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Jul 27Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?
Jun 17Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital
May 30Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All
May 12Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Mar 30Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?
Mar 09Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares
Feb 16
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jan 26NuVasive stock gains on study results of its X360 surgery approach
Jan 06What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 05Rendement pour les actionnaires
| NUVA | US Medical Equipment | US Marché | |
|---|---|---|---|
| 7D | 1.5% | 3.9% | 4.9% |
| 1Y | -8.3% | 11.2% | 25.6% |
Rendement vs Industrie: NUVA underperformed the US Medical Equipment industry which returned -3.3% over the past year.
Rendement vs marché: NUVA underperformed the US Market which returned 14.1% over the past year.
Volatilité des prix
| NUVA volatility | |
|---|---|
| NUVA Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: NUVA has not had significant price volatility in the past 3 months.
Volatilité au fil du temps: NUVA's weekly volatility (4%) has been stable over the past year.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1997 | 3,000 | Chris Barry | www.nuvasive.com |
NuVasive, Inc. Résumé des fondamentaux
| NUVA statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$2.08b |
| Bénéfices(TTM) | US$28.45m |
| Recettes(TTM) | US$1.23b |
73.3x
Ratio P/E1.7x
Ratio P/SLe site NUVA est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| NUVA compte de résultat (TTM) | |
|---|---|
| Recettes | US$1.23b |
| Coût des recettes | US$347.50m |
| Marge brute | US$878.73m |
| Autres dépenses | US$850.28m |
| Les revenus | US$28.45m |
Derniers bénéfices déclarés
Jun 30, 2023
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 0.54 |
| Marge brute | 71.66% |
| Marge bénéficiaire nette | 2.32% |
| Ratio dettes/capitaux propres | 89.1% |
Quelles ont été les performances à long terme de NUVA?
Voir les performances historiques et les comparaisons